Gina Consylman, Chief Accounting Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 207 shares at $14.34 ($3K) on 2017-08-18, disclosed to the SEC on 2017-08-22.
Scheduled sale ($3k) by Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IRWD | SELL | 2020-02-25 | $217K | — | Filing → |
| IRWD | SELL | 2019-11-12 | $17K | — | Filing → |
| IRWD | SELL | 2019-08-20 | $2K | — | Filing → |